Quick Takeaways
- FULLER & THALER ASSET MANAGEMENT, INC. filed SCHEDULE 13G for Indivior Pharmaceuticals, Inc. Common Stock (INDV).
- Disclosed ownership: 5.1%.
- Date of event: 31 Dec 2025.
FULLER & THALER ASSET MANAGEMENT, INC. - 31 Dec 2025 SCHEDULE 13G Report for Indivior Pharmaceuticals, Inc. Common Stock (INDV)
- Filing Manager
- FULLER & THALER ASSET MANAGEMENT, INC.
- Reporting Manager
- Fuller & Thaler Asset Management, Inc.
- Symbol
- INDV
- Shares outstanding
- 124,932,033 shares
- Disclosed Ownership
- 6,371,534 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 13:37:56 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FULLER & THALER ASSET MANAGEMENT, INC. disclosed 5.1% ownership in Indivior Pharmaceuticals, Inc. Common Stock (INDV) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 13:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Fuller & Thaler Asset Management, Inc. | 5.1% | 6,371,534 | 6,193,614 | 0 | /s/ Hanna Zanoni | Chief Compliance Officer |